Reproductive genetics A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure

Tanguy Corre1, Julia Schuettler2, Silvia Bione1,3, Anna Marozzi4, Luca Persani5,6, Raffaella Rossetti5,6, Francesca Torricelli7, Irene Giotti7, Peter Vogt2, and Daniela Toniolo1,3,8 on behalf of the Italian Network for the study of Ovarian Dysfunctions† Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 4A2, Via Olgettina 58, 20132 Milano, Italy Department of Gynecological Endocrinology and Reproductive Medicine, University of Heidelberg, Heidelberg, Germany Institute of Molecular GeneticsCNR, Pavia, Italy Department of Biology and Genetics for Medical Sciences, University of Milano, Milano, Italy Department of Medical Sciences, University of Milan, Milano, Italy Laboratory of Experimental Endocrinology, IRCCS Istituto Auxologico Italiano, Milano, Italy Department of Genetic Diagnosis, Careggi University Hospital, University of Firenze, Firenze, Italy Correspondence address. Tel þ39-02-26434764; Fax: þ39-02-26434767; E-mail: daniela.toniolo@hsr.it

[1]  S. Bione,et al.  Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. , 2008, Human molecular genetics.

[2]  A. Rajkovic,et al.  Transcription factor FIGLA is mutated in patients with premature ovarian failure. , 2008, American journal of human genetics.

[3]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[4]  S. Christin‐Maitre.  The role of hormone replacement therapy in the management of premature ovarian failure , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[5]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[6]  A. Rajkovic,et al.  NOBOX homeobox mutation causes premature ovarian failure. , 2007, American journal of human genetics.

[7]  L. Singh,et al.  Expansion of the germline analysis for the INHA gene in Indian women with ovarian failure. , 2006, Human reproduction.

[8]  R. Frydman,et al.  Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. , 2006, European journal of endocrinology.

[9]  T. Strowitzki,et al.  Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. , 2006, Current medicinal chemistry.

[10]  S. Bione,et al.  Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. , 2006, Human reproduction.

[11]  L. Singh,et al.  Missense mutations in the BMP15 gene are associated with ovarian failure , 2006, Human Genetics.

[12]  Hajime Nawata,et al.  INHA promoter polymorphisms are associated with premature ovarian failure. , 2005, Molecular human reproduction.

[13]  N. Suzumori,et al.  Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure. , 2005, Fertility and sterility.

[14]  P. Beck‐Peccoz,et al.  Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. , 2004, American journal of human genetics.

[15]  K. Cha,et al.  G769A variation of inhibin alpha-gene in korean women with premature ovarian failure. , 2004, Yonsei medical journal.

[16]  F. Parazzini.  Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy. , 2003, Maturitas.

[17]  K. Loveland,et al.  Inhibins, activins and follistatin in reproduction. , 2002, Human reproduction update.

[18]  A. Shelling,et al.  Identification of novel mutations in FOXL2 associated with premature ovarian failure. , 2002, Molecular human reproduction.

[19]  C. Porta,et al.  Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. , 2002, Human reproduction.

[20]  K. Aittomäki,et al.  A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. , 2002, The Journal of clinical endocrinology and metabolism.

[21]  A. Shelling,et al.  Inhibin: A Candidate Gene for Premature Ovarian Failure , 2001 .

[22]  S. Sherman.  Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect? , 2000, American journal of human genetics.

[23]  A. Chapelle,et al.  Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure , 1995, Cell.

[24]  Kathryn J. Woad,et al.  Investigating the association between inhibin alpha gene promoter polymorphisms and premature ovarian failure. , 2009, Fertility and sterility.

[25]  A. Shelling,et al.  Functional analysis of the human inhibin alpha subunit variant A257T and its potential role in premature ovarian failure. , 2007, Human reproduction.

[26]  S. Campo,et al.  Controversial role of inhibin alpha-subunit gene in the aetiology of premature ovarian failure. , 2006, Human reproduction.

[27]  M. Sowers,et al.  Premature menopause in a multi-ethnic population study of the menopause transition. , 2003, Human reproduction.